Actualizado 10/07/2012 03:33
- Comunicado -

New Breast Cancer Treatment Available in France (y 2)

With operations in the U.S., Asia, Europe and its domestic home market of Japan, Eisai employs more than 11,000 people worldwide. In Europe, Eisai undertakes sales and marketing operations in over 20 markets, including the United Kingdom, France, Germany, Italy, Spain, Switzerland, Sweden, Ireland, Austria, Denmark, Finland, Norway, Portugal, Iceland, Czech Republic, Slovakia, the Netherlands, Belgium, Luxembourg, the Middle East and Russia.

For further information please visit our web site http://www.eisai.com

References

        
        1) SPC Halaven (updated March 2011). Available at:
          http://www.medicines.org.uk/EMC/medicine...
          . Last accessed October 2011
        2) Cortes J et al. The Lancet. 2011; 377: 914-923
        3) GLOBOCAN. 2008. Breast Cancer in France. Available at:
          http://globocan.iarc.fr/factsheets/popul... Last
          accessed November 2011
        4) Launois R et al. PharmacoEconomics 1997: 11(5): 495-497
        5) Eisai. Data on file

CONTACT: Media Enquiries: Eisai Europe Ltd, Charlotte Andrews / CressidaRobson, +44(0)7947-231513 / +44(0)790-831-4155, charlotte_andrews@eisai.net/ cressida_robson@eisai.net ; Tonic Life Communications, Benjamyn Tan /Leah Peyton, +44(0)207-798-9262 / +44(0)7788-191434,benjamyn.tan@toniclc.com / eisaioncology@toniclc.com

Contenido patrocinado